DOCU vs ZNTL · P/E 15, rev $1.71B vs $257.7M cap
DocuSign Inc (DOCU) versus Zentalis Pharmaceuticals Llc (ZNTL) — a side-by-side from cached financials, not a winner call.
DocuSign Inc (DOCU) is a software - application company listed on US.
Zentalis Pharmaceuticals Llc (ZNTL) is a biotechnology company listed on NASDAQ.
Latest reported DOCU revenue for 2026-07-31 was $1.71B. Net income was $155.9M. DOCU currently screens at market cap $15.74B and trailing P/E 14.8.
Latest reported ZNTL revenue for 2025-09-30 was $0. Net income was -$26.7M. ZNTL currently screens at market cap $257.7M.
DOCU currently screens at market cap $15.74B and trailing P/E 14.8. ZNTL currently screens at market cap $257.7M.
Not investment advice. Open the DOCU and ZNTL stock pages for the full models.
Not investment advice.